Generics BulletinTonix Pharmaceuticals’ Tonmya (TNX-102 SL) obtained US Food and Drug Administration approval on Aug. 15, becoming the first new drug therapy for fibromyalgia in more than 16 years. The firm acquired a
ScripTonix Pharmaceuticals’ Tonmya (TNX-102 SL) obtained US Food and Drug Administration approval on Aug. 15, becoming the first new drug therapy for fibromyalgia in more than 16 years. The firm acquired a
Pink SheetWith 10 novel applications with August user fee goal dates remaining under review, the US Food and Drug Administration could make some headway toward FDA Commissioner Martin Makary’s ambitious 2025 ap
ScripAntibody-drug conjugate (ADC) developer Adcendo has been busy during the last year and a half since the company raised a €31m ($32.3m) extension of the €51m ($53.2m) series A it originally raised in 2